Capstan Therapeutics
Capstan Therapeutics is a biotechnology company focused on advancing in vivo cell reprogramming through RNA delivery using targeted lipid nanoparticles (tLNP). Its core platform technology aims to create transformative therapies for various diseases by delivering payloads to reprogram specific cell types within the body. This approach offers potential applications across autoimmune disorders, oncology, fibrosis, and monogenic blood disorders.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $175M
Date: 20-Mar-2024
Investors: RA Capital Management, Forbion, Johnson & Johnson Innovation - JJDC, Mubadala Capital, Perceptive Advisors, Sofinnova Investments, Alexandria Venture Investments, Bristol Myers Squibb, Eli Lilly and Company, Leaps by Bayer, Novartis Venture Fund, OrbiMed, Pfizer Ventures, Polaris Partners, Vida Ventures
Markets: Biotechnology, RNA Therapeutics, Immunology, Oncology, Autoimmune Disorders
HQ: San Diego, California, United States
Founded: 2021
Website: https://www.capstantx.com
LinkedIn: https://www.linkedin.com/company/capstan-therapeutics/
Twitter: https://twitter.com/capstantx
Crunchbase: https://www.crunchbase.com/organization/capstan-therapeutics
Leave a Comment
Comments
No comments yet.